2Johnston C I. Angiotensin receptor antagonists: focus on losartan[J]. Lancet, 1995,346(8987):1403-1407.
3Mento P F, Wilkes B M. Plasma angiotensin and blood pressure during converting enzyme inhibition[J]. Hypertension, 1987,9(6 Pt2):Ⅲ42-48.
4Touyz R M, Endemann D, He G, et al. Role of AT2 receptors in angiotensin Ⅱ-stimulated contraction of small mesenteric arteries in young SHR[J]. Hypertens, 1999,33(1Part Ⅱ):366-372.
5Ji H, Leung M, Zhang Y, et al. Differential structural requirements for specific binding of nonpeptide and peptide antagonists to the AT1 angiotensin receptor: identification of amino acid residues that determine binding of the antihypertensive drug losartan[J]. J Biol Chem, 1994,269(24):16533-16536.
3Rose M;McMahon FG.Some problems with anti_ hypertensive drug studies in the context of the new guide line,1990.
4Giuseppe M;Daniele A;Gerard J.Effect of the converting enzyme inhibition benazepril on the pro_gression of chronic renal insufficiency[J],1996.
5Hollenberg NK;Adams DF.The renal circulation in hypertensive disease[J],1976.
6Valve E;Gammaro L;Bedogna V.Systemic and renal haemodynamic changes of two_months treatment with enalapril in patients with essential hypertension,1987.
7Richer C;Doussau MP;Giudicelli JF.Systemic and regional hemodynamic profile of five angiotensin_converting enzyme inhibitions in the spontaneously hypertensive rat[J],1987.
8Heeg JE;De Jong PE;Van der Hem GK.Reduction of proteinura by angiotensin_converting enzyme inhibition[J],1987.
9Dwokin L;Feinet HD;Randazzo J.Glomerular hy_ pertension and injury in the deoxycortcosterone_salt rats on antighpertensive therapy[J],1987.
10Bohrer MP;Deen WM;Robertson CR.Mecha_ nism of angiotensin Ⅱ _proteinuria in the rat,1977.
